Bioinformatics | Drug Development | Pharmacology AI-based prediction of protein-ligand binding affinity and discovery of potential natural product inhibitors against ERK2. June 3, 2024
Artificial Intelligence | Bioinformatics | Pharmacology De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning. February 3, 2021